Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Novel therapies for children with severe asthma
Top Ten Searches
hla beta 2 probiotics hypo allergenic scid urticaria aeroallergens asthma angioedema hivYour Article Summary
See Latest ArticlesMinimal persistent inflammation in allergic rhinitis: implications for current treatment strategies
Clinical and Experimental Immunology, 11/03/09
Canonica GW et al. – Treating overt allergy symptoms as well as this underlying inflammatory state requires agents that have well–established clinical efficacy, convenient administration, potent anti–inflammatory effects and proven long–term safety, so that long–term continuous administration is feasible. Of the three major classes of commonly used allergic rhinitis medications – intranasal corticosteroids, anti–histamines, and anti–leukotrienes – intranasal corticosteroids appear to represent the most reasonable therapeutic option in patients who would benefit from continuous inhibition of persistent inflammation.
Today in Allergy/Anaphylaxis...keeping you current
Receive free subspecialty "5-minute updates" via email
Oral Allergy Syndrome
Allergology International, 10/30/09
Role of adenoids and adenoiditis in children with allergy and otitis media
Current Allergy and Asthma Reports, 10/22/09
Montelukast in the treatment of asthma and beyond
Expert Review of Clinical Immunology, 11/23/09
Sponsor
Article Search
Sponsor